Form 4: Mario Gabelli Boosts GRX.E Preferred Share Holdings

Mario J. Gabelli, a director and 10% owner of Gabelli Healthcare & WellnessRx Trust, reported significant net acquisitions of Series E Cumulative Preferred Shares.

Summary

• Mario J. Gabelli, a Director, 10% Owner, and Control Person of Adviser for Gabelli Healthcare & WellnessRx Trust (GRX.E), reported changes in his beneficial ownership of Series E Cumulative Preferred Shares.
• On December 26, 2025, Mr. Gabelli acquired 500,000 Series E Cumulative Preferred Shares indirectly through Associated Capital Group, Inc. (ACG) at a price of $10 per share. Following this transaction, ACG beneficially owns 700,000 shares.
• An additional 200,000 Series E Cumulative Preferred Shares were acquired indirectly through GGCP, Inc. (GGCP) at $10 per share. GGCP beneficially owns 200,000 shares after this transaction.
• Mr. Gabelli also directly acquired 1,000,000 Series E Cumulative Preferred Shares at $10 per share, resulting in 1,000,000 directly owned shares.
• Another 100,000 Series E Cumulative Preferred Shares were acquired indirectly through MJG Associates at $10 per share, bringing MJG Associates' beneficial ownership to 100,000 shares.
• Concurrently, 200,000 Series E Cumulative Preferred Shares were surrendered directly by Mr. Gabelli at $10 per share, in accordance with a Right to Put to the Fund up to 100% of Outstanding Series E Cumulative Preferred Shares.

Sentiment

Score: 7

Explanation: The filing indicates substantial net acquisitions of preferred shares by a key insider and control person, Mario J. Gabelli, across various direct and indirect holdings. This suggests confidence in the issuer, despite a concurrent planned surrender of a smaller portion of shares.

Positives

• Significant net acquisition of 1,600,000 Series E Cumulative Preferred Shares by a key insider, Mario J. Gabelli, across direct and indirect holdings, totaling $16,000,000 in value.
• The acquisitions were made at a consistent price of $10 per share, indicating a specific valuation for these preferred shares by the insider.

Negatives

• A disposition of 200,000 Series E Cumulative Preferred Shares directly owned by Mr. Gabelli, although this was a planned surrender in accordance with a 'Right to Put to the Fund'.

Future Outlook

This Form 4 filing details past and future insider transactions and does not provide forward-looking statements or guidance regarding the company's operations or financial performance.

Management Comments

• Mario J. Gabelli disclaims beneficial ownership of shares held by Associated Capital Group, Inc. (ACG) in excess of his indirect pecuniary interest, as he has less than a 100% interest in ACG, despite being its Executive Chair and controlling shareholder.
• Mario J. Gabelli disclaims beneficial ownership of shares held by GGCP, Inc. (GGCP) in excess of his indirect pecuniary interest, as he has less than a 100% interest in GGCP, despite being its Chief Executive Officer, a director, and controlling shareholder.

Industry Context

This filing is specific to insider transactions of Gabelli Healthcare & WellnessRx Trust and does not provide broader industry trends or competitive analysis.

Related Party Transactions

• Mario J. Gabelli is the Executive Chair and controlling shareholder of Associated Capital Group, Inc. (ACG), which indirectly acquired 500,000 Series E Cumulative Preferred Shares.
• Mario J. Gabelli is the Chief Executive Officer, a director, and the controlling shareholder of GGCP, Inc. (GGCP), which indirectly acquired 200,000 Series E Cumulative Preferred Shares.
• Mario J. Gabelli is the sole shareholder, director, and employee of MJG Associates, which indirectly acquired 100,000 Series E Cumulative Preferred Shares.

Stakeholder Impact

• Shareholders may view the significant net acquisition of preferred shares by a prominent insider like Mario J. Gabelli as a positive signal of management's confidence in the company's value and future prospects.

Key Dates

Keywords

Gabelli Healthcare & WellnessRx Trust, GRX.E, Mario J. Gabelli, Form 4, Insider Transaction, Beneficial Ownership, Preferred Shares, SEC Filing